This invention concerns a compound of formula ##STR00001## a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine and a stereochemically isomeric form thereof, wherein R.sup.1 is hydrogen, hydroxy, cyano, amino, mono-or di(C.sub.1-4alkyl)amino, formyl, carboxyl, C.sub.1-6alkyl, hydroxyC.sub.1-6alkyl, polyhaloC.sub.1-6alkyl, C.sub.2-6alkenyl, C.sub.2-6alkynyl, C.sub.3-7cycloalkyl, C.sub.1-6alkyloxy, C.sub.1-6alkylcarbonyl, aminocarbonyl, --S(.dbd.O).sub.m--NH.sub.2, mono-or di(C.sub.1-4alkyl)aminocarbonyl, C.sub.1-6alkyloxycarbonyl, C.sub.1-6alkylcarbonyloxy, aryl, arylC.sub.1-6alkyl or aryloxy; R.sup.2 is hydrogen; halo; mercapto; formyl; cyano; carboxy; azido; hydroxy; oxiranyl; amino; mono- or di(C.sub.1-4alkyl)amino; formylamino; R.sup.5R.sup.6N--C(.dbd.O)--; R.sup.7--N.dbd.C(R.sup.8)--; C.sub.1-6alkyl-S(.dbd.O)m; aryl-S(.dbd.O).sub.m; optionally substituted C.sub.2-6alkenyl; optionally substituted C.sub.2-6alkynyl; C.sub.1-6alkyloxy; hydroxyC.sub.1-6alkyloxy; aminoC.sub.1-6alkyloxy; mono- or di(C.sub.1-4alkyl)amino-C.sub.1-6alkyloxy; C.sub.1-6alkylcarbonyl; arylcarbonyl; Het.sup.1carbonyl; C.sub.1-6alkyloxycarbonyl; C.sub.1-6alkylcarbonyloxy; aryl; aryloxy; arylC.sub.1-6alkyloxy; arylthio; arylC.sub.1-6alkylthio; mono- or di(aryl)amino; Het.sup.1; Het.sup.1oxy; Het.sup.1thio; Het.sup.1C.sub.1-6alkyloxy; Het.sup.1C.sub.1-6alkylthio; mono- or di(Het.sup.1)amino; C.sub.3-7cycloalkyl; C.sub.3-7cycloalkyloxy; C.sub.3-7cycloalkylthio; C.sub.1-6alkylthio; hydroxyC.sub.1-6alkylthio; aminoC.sub.1-6alkylthio; mono- or di(C.sub.1-4alkyl)aminoC.sub.1-6alkylthio; optionally substituted C.sub.1-6alkyl; R.sup.3 or R.sup.4 each independently represent optionally be substituted phenyl, pyridyl, pyrimidinyl, pyrazinyl or pyridazinyl; --X-- is a bivalent radical selected from --NR.sup.14--, --NH--NH--, --N.dbd.N--, --O--, --C.sub.1-6alkanediyl-, --C(.dbd.O)--, --CHOH--, --S--, --S(.dbd.O).sub.m--; aryl is optionally substituted phenyl; Het.sup.1, Het.sup.2 or Het.sup.3 represent an optionally substituted monocyclic or bicyclic heterocycle; their use as a medicine, their processes for preparation and pharmaceutical compositions comprising them.

 
Web www.patentalert.com

< Pyrazole compounds

< Non-nucleoside reverse transcriptase inhibitors

> N.sup.4-acylcytosine nucleosides for treatment of viral infections

> Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors

~ 00286